Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Nov 21 2025
Oct 21 2025
Nov 3 2025
Jul 30 2026
Aug 23 2025